Sai Life Sciences’ unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s upper limit of Rs 549.
Fortis Healthcare Q4 Results: Net profit falls 7% to Rs 188 crore
Fortis Healthcare Ltd on Tuesday reported a 7.44 per cent decline in consolidated net profit at Rs 188.02 crore in the fourth quarter ended March